International Journal of Molecular Sciences·Aug 13Role of Lipoprotein(a) in Aortic Valve Calcification: Inflammatory and Oxidative Mechanisms InvolvedReviewMechanismsPaper
International Journal of Cardiology Cardiovascular Risk and Prevention·Aug 11Risk stacking in peripheral artery disease (PAD): Integrating genetics, cardiometabolic disease and social determinants of health to explain worsening PAD outcomesReviewPeripheral artery diseasePaper
Journal of Clinical Lipidology·Aug 9Direct Lp(a)-C measurement reveals formula-based overestimation of Lp(a)-C and underestimation of corrected LDL-C: Implications for LDL-C target interpretationCross-sectional study of 278 peopleLDL-CPaper
Research Square·Aug 7Lipoprotein(a) and Cardiovascular-Kidney-Metabolic Syndrome: Stage-Specific Associations With All-Cause Mortality and Major Adverse Cardiovascular Events in the UK BiobankPreprint: cohort study of 337,164 peopleLipoproteinPaper
Journal of Clinical Lipidology·Aug 6Distribution of lipoprotein(a) and its association with atherosclerotic cardiovascular disease in a large real-world Polish cohortCohort study of 23,654 peopleLipoproteinPaper
European Journal of Preventive Cardiology·Aug 4The role of lipoprotein (a) in premature cardiovascular disease: primed for preventionReviewLipoproteinPaper
Metabolism·Aug 1The association of MASLD, lipoprotein(a) and long-term outcomes: Results from the multi-ethnic study of atherosclerosisCohort study in peopleAtherosclerosisPaper
Journal of Clinical Lipidology·Jul 30Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causationCohort study of 312,332 peopleLipoproteinPaper
bioRxiv·Jul 30Lipoprotein(a) promotes thrombosis through platelet activation and promotion of a lysis-resistant thrombus architecturePreprint: experiments in miceMechanismsPaper
ADA Scientific Sessions 2026 Abstract·Jun 5Integrating Lipoprotein(a) with Retinal Imaging Biomarkers for Cardiovascular Risk Assessment: UK Biobank AnalysisCohort study of 50,475 peopleLipoproteinPaper
European Journal of Internal Medicine·Jun 2Lipoprotein(a) and risk of dementia: A propensity score-matched real-world analysis from a global federated research networkCohort study of 151,117 peopleFrontotemporal dementiaPaper
European Journal of Preventive Cardiology·Mar 31Machine Learning-driven Prioritisation of Lipoprotein(a) Testing: Model Development and ValidationComputational studyLipoproteinPaper
medRxiv·Mar 30Longitudinal Variability of Lipoprotein(a) in Children with Type 1 Diabetes: Implications for Cardiovascular Risk StratificationPreprint: cohort study of 287 peopleLipoproteinPaper
Revista Portuguesa de Cardiologia·Mar 29Lipoprotein(a) and acute coronary syndrome: Associations with sex, age and traditional cardiovascular risk factorsCross-sectional study of 388 peopleLipoproteinPaper
European Heart Journal·Mar 29Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in menCohort study of 189,013 peopleVenous thromboembolismPaper
HRB Open Res·Mar 26Assessing Long-Term Stability of Lipoprotein(a) in Frozen Blood Plasma Samples: A 14-Year Analysis from The Irish Longitudinal Study on Ageing (TILDA)Preprint: cohort study in peopleLipoproteinPaper
Journal of the Formosan Medical Association·Mar 262026 Consensus and review of Lipoprotein(a) from Taiwan Society of Lipid and Atherosclerosis: Molecular pathogenesis, epidemiology, clinical implications, and advances in diagnostic strategiesReviewLipoproteinPaper
Lakartidningen·Mar 20Lipoprotein(a) - the hereditary risk factor for cardiovascular diseaseReviewLipoproteinPaper
Atherosclerosis·Mar 19Association of Lp(a) with coronary plaque burden and high-risk plaque features: A meta-analysis of imaging studiesMeta-analysis of observational studiesBiomarkersPaper
High Blood Pressure & Cardiovascular Prevention·Mar 18Lipoprotein(a) Does Not Correlate with Hypertensive Mediated Organ Damage and Subsequent Cardiovascular Events in a Primary Prevention CohortCohort study of 747 peopleLipoproteinPaper
Journal of the American Heart Association·Mar 18Association Between Lipoprotein(a) Testing, Lipid-Lowering Therapy Intensification, and Low-Density Lipoprotein Cholesterol Goal Attainment: Findings From the Veterans Affairs Health SystemCohort study of 6,941,840 peopleLipoproteinPaper
Anatolian Journal of Cardiology·Mar 18Managing Progressive Atherosclerotic Cardiovascular Disease in a Patient with Elevated Lipoprotein(a)ReviewAtherosclerotic cardiovascular diseasePaper
Acta Cardiologica·Mar 17The influence of lipoprotein(a) on coronary revascularization after percutaneous coronary interventionMeta-analysisLipoproteinPaper
Journal of the American College of Cardiology·Mar 16Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a): A Multicohort StudyCohort study of 11,319 peopleCoronary artery calciumPaper
Journal of Clinical Medicine·Mar 14Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary SyndromeReviewLipoproteinPaper
European Journal of Preventive Cardiology·Mar 12Lipoprotein(a), Atherosclerotic Plaque Burden, and Long-term Cardiovascular Outcomes in Patients With Coronary Artery DiseaseCohort study of 798 peopleLipoproteinPaper
Circulation Journal·Mar 9Prognostic Value of Serum Lipoprotein(a) Levels in Japanese Patients With ST-Segment Elevation Myocardial InfarctionCohort study of 868 peopleLipoproteinPaper
Reviews in Cardiovascular Medicine·Mar 6The Lipoprotein(a) Implementation Gap: Bridging Evidence and Clinical PracticeReviewLipoproteinPaper
International Journal of Cardiology Cardiovascular Risk and Prevention·Mar 5Elevated lipoprotein(a) and adverse outcomes in advanced coronary artery calcification: An intravascular ultrasound studyCohort study of 292 peopleLipoproteinPaper
American Journal of Preventive Cardiology·Mar 2Lipoprotein(a) epidemiology and role in secondary and primary-and-a-half cardiovascular prevention: From subclinical atherosclerosis to coronary eventsCross-sectional study of 1,043 peopleLipoproteinPaper